CytoDyn (OTC: CYDY) to Present New Data from Study of Investigational HIV Therapy Leronlimab (PRO 140), a Long-Acting, Single-Agent Maintenance Therapy at CROI 2019

VANCOUVER, Washington, Feb. 27, 2019 — CytoDyn Inc. (OTC.QB: CYDY), a late stage biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, today announced that data from its study of leronlimab […]


Nightfood (OTC: NGTF) Ice Cream Coupon Program Launches March 1st, Over 33,000 Consumer Sign-Ups to Date

Tarrytown, NY, Feb 28, 2019 – Nightfood, Inc. (OTC QB: NGTF), the innovative company solving America’s $50 billion-dollar nighttime snacking problem, has announced that over 33,000 consumers across the country have already requested coupons for […]